NEW YORK (GenomeWeb News) – Transgenomic reported after the close of the market Wednesday that its fourth quarter revenues fell 12 percent year over year.

The Omaha, Neb.-based molecular diagnostics firm reported total revenues of $6.2 million for the three months ended Dec. 31, compared to $7.2 million for the fourth quarter of 2012. Its laboratory services revenue dropped to $2.8 million from $4.8 million, while its diagnostics tools business saw revenues rise to $3.4 million from $2.5 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.